Lianhai Zhang

Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised controlled trial

Xiaotian Zhang, Liang Han, Ziyu Li et al. · The Lancet Oncology · 2021 · 414 citations

D2 Gastrectomy, Surgical Oncology, Esophageal Cancer +10

A proteomic landscape of diffuse-type gastric cancer

Sai Ge, Xia Xia, Chen Ding et al. · Nature Communications · 2018 · 315 citations · Full text

<i>FGFR2</i> Gene Amplification in Gastric Cancer Predicts Sensitivity to the Selective FGFR Inhibitor AZD4547

Liang Xie, Xinying Su, Lin Zhang et al. · Clinical Cancer Research · 2013 · 236 citations

Multi-omics characterization of molecular features of gastric cancer correlated with response to neoadjuvant chemotherapy

Ziyu Li, Xiangyu Gao, Xinxin Peng et al. · Science Advances · 2020 · 124 citations · Full text

Level of circulating PD-L1 expression in patients with advanced gastric cancer and its clinical implications.

Zhixue Zheng, Zhaode Bu, Xijuan Liu et al. · PubMed · 2014 · 121 citations · Full text